SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-026568
Filing Date
2012-05-07
Accepted
2012-05-07 16:18:09
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v311716_10q.htm 10-Q 496587
2 EXHIBIT 31.1 v311716_ex31-1.htm EX-31.1 10692
3 EXHIBIT 31.2 v311716_ex31-2.htm EX-31.2 10738
4 EXHIBIT 32.1 v311716_ex32-1.htm EX-32.1 3585
5 EXHIBIT 32.2 v311716_ex32-2.htm EX-32.2 3604
  Complete submission text file 0001144204-12-026568.txt   2177997

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT heb-20120331.xml EX-101.INS 260125
7 XBRL TAXONOMY EXTENSION SCHEMA heb-20120331.xsd EX-101.SCH 14703
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE heb-20120331_cal.xml EX-101.CAL 33512
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE heb-20120331_def.xml EX-101.DEF 8694
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE heb-20120331_lab.xml EX-101.LAB 142091
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE heb-20120331_pre.xml EX-101.PRE 92854
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13441 | Film No.: 12818073
SIC: 2836 Biological Products, (No Diagnostic Substances)